No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer

被引:64
作者
Renkonen-Sinisalo, L
Sipponen, P
Aarnio, M
Julkunen, R
Aaltonen, LA
Sarna, S
Järvinen, HJ
Mecklin, JP
机构
[1] Univ Helsinki, Cent Hosp, Div Gastroenterol, Dept Surg, FI-00029 Helsinki, Finland
[2] Jorvi Hosp, Dept Pathol, SF-02740 Espoo, Finland
[3] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland
[4] Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland
[5] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[6] Jyvaskyla Cent Hosp, Jyvaskyla, Finland
关键词
gastric cancer; HNPCC; surveillance;
D O I
10.1080/00365520252903134
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The DNA mismatch repair gene mutations underlying hereditary non-polyposis colorectal cancer syndrome (HNPCC) also predispose. besides colorectal and endometrial cancer. to gastric cancer. usually of the intestinal type. The carcinogenetic pathway behind the elevated gastric cancer risk is largely unknown. Methods: The aim of this study was to determine whether there are any premalignant lesions to search for in gastric surveillance in HNPCC by comparing gastric histopathology between mutation-positive and mutation-negative family members. We searched for differences in occurrence of Helicobacter pylori. inflammation, atrophy. intestinal metaplasia and dysplastic changes. Upper gastrointestinal endoscopy was performed for 73 mutation-positive and 32 mutation-negative family members. Results: One case of duodenal cancer was detected in the mutation-positive group, but no gastric neoplastic lesions were seen in either group. There were no differences in the occurrence of polyps, H. pylori, inflammation, activity. atrophy nor intestinal metaplasia tested with binaric, logistic. regression analysis. Conclusions: We conclude that surveillance gastroscopy may not be beneficial in HNPCC, since neither cases, of early cancer nor premalignant lesions could be detected in our series of 73 mutation-positive subjects.
引用
收藏
页码:574 / 577
页数:4
相关论文
共 17 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]  
Aarnio M, 1997, INT J CANCER, V74, P551, DOI 10.1002/(SICI)1097-0215(19971021)74:5<551::AID-IJC13>3.0.CO
[4]  
2-9
[5]  
CORREA P, 1992, CANCER RES, V52, P6735
[6]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[7]  
Holmberg M, 1998, Hum Mutat, V11, P482
[8]   Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer [J].
Järvinen, HJ ;
Aarnio, M ;
Mustonen, H ;
Aktan-Collan, K ;
Aaltonen, LA ;
Peltomäki, P ;
de la Chapelle, A ;
Mecklin, JP .
GASTROENTEROLOGY, 2000, 118 (05) :829-834
[9]  
Lynch HT, 1999, J MED GENET, V36, P801
[10]   FOUNDING MUTATIONS AND ALU-MEDIATED RECOMBINATION IN HEREDITARY COLON-CANCER [J].
NYSTROMLAHTI, M ;
KRISTO, P ;
NICOLAIDES, NC ;
CHANG, SY ;
AALTONEN, LA ;
MOISIO, AL ;
JARVINEN, HJ ;
MECKLIN, JP ;
KINZLER, KW ;
VOGELSTEIN, B ;
DELACHAPELLE, A ;
PELTOMAKI, P .
NATURE MEDICINE, 1995, 1 (11) :1203-1206